Scanadu Urine Device Validation Study Protocol

NCT ID: NCT02973178

Last Updated: 2016-11-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

300 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-08-31

Study Completion Date

2016-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will test Scanadu Urine Device for clinical performance and usability.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The objectives of this study are to:

* Evaluate and validate the clinical performance of the Scanadu Urine Device in the hands of intended users as compared to: the visual read of chemical test strips performed by lab technicians utilizing the Siemens Multistix® 10SG technology (K905396).
* Evaluate and validate the user-interface of the Scanadu Urine Device by the intended users for human factors and user interface of the Scanadu Urine Device.
* Evaluate the reproducibility in the hands of the lay-users after repeated testing of samples with known test levels

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Urinary Tract Infections Proteinuria Ketone Urine Hematuria Glucose Intolerance

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Usability

Evaluate and validate the user-interface of the Scanadu Urine Device by the intended users for human factors and user interface of the Scanadu Urine Device.

Group Type OTHER

Scanadu Urine Device

Intervention Type DEVICE

Device to allow lay user to perform urinalysis test at home.

Method Comparison

Evaluate and validate the clinical performance of the Scanadu Urine Device in the hands of intended users as compared to:

* The visual read of chemical test strips performed by lab technicians utilizing the Siemens Multistix® 10SG technology (K905396),
* Scanadu Urine Device tests performed by lab technicians.

Group Type ACTIVE_COMPARATOR

Scanadu Urine Device

Intervention Type DEVICE

Device to allow lay user to perform urinalysis test at home.

Reproducibility

Evaluate the reproducibility in the hands of the lay-users after repeated testing of samples with known test levels.

Group Type OTHER

Scanadu Urine Device

Intervention Type DEVICE

Device to allow lay user to perform urinalysis test at home.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Scanadu Urine Device

Device to allow lay user to perform urinalysis test at home.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Female and male
* 18 years old or older
* Pregnant or not pregnant
* Must have experience using an Apple iPhone
* Have no visual impairments
* Able to hold Smart Phone horizontally in raised dominant hand
* Must be able to read and understand English
* Must provide Informed Consent

Exclusion Criteria

* Has a known history of a visual impairment that may affect reading and navigating the Scanadu Urine app
* Unable to void and collect urine specimen for testing
* Unable to hold phone steady (horizontally) or has history of tremors or conditions such as Parkinson's disease
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Scanadu, Inc.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

West Coast Research, LLC

Mountain View, California, United States

Site Status RECRUITING

West Coast Research, LLC

San Leandro, California, United States

Site Status COMPLETED

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Jenny Li

Role: CONTACT

Phone: 650-567-6389

Email: [email protected]

Daya Ranamukhaarachchi

Role: CONTACT

Phone: 301-569-1213

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Tim Davis

Role: primary

Jenny Li

Role: backup

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

FO-004

Identifier Type: -

Identifier Source: org_study_id